Home › Compare › PEARW vs BTI

PEARW vs BTI: Dividend Comparison 2026

PEARW yields 33898.31% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEARW wins by $9.963396520724352e+21M in total portfolio value
10 years
PEARW
PEARW
● Live price
33898.31%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.963396520724352e+21M
Annual income
$9,905,911,559,981,649,000,000,000,000.00
Full PEARW calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — PEARW vs BTI

📍 PEARW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEARWBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEARW + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PEARW pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEARW
Annual income on $10K today (after 15% tax)
$2,881,355.93/yr
After 10yr DRIP, annual income (after tax)
$8,420,024,825,984,401,000,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, PEARW beats the other by $8,420,024,825,984,401,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEARW + BTI for your $10,000?

PEARW: 50%BTI: 50%
100% BTI50/50100% PEARW
Portfolio after 10yr
$4.981698260362176e+21M
Annual income
$4,952,955,779,990,824,000,000,000,000.00/yr
Blended yield
99.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

PEARW
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-9.0
Piotroski
2/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEARW buys
0
BTI buys
0
No recent congressional trades found for PEARW or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEARWBTI
Forward yield33898.31% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$9.963396520724352e+21M$37.7K ✓
Annual income after 10y$9,905,911,559,981,649,000,000,000,000.00 ✓$2,786.64
Total dividends collected$9.959616773768018e+21M$14.3K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: PEARW vs BTI ($10,000, DRIP)

YearPEARW PortfolioPEARW Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$3,400,531$3,389,830.51$11,299$598.92+$3.39M → PEARW
2$1,080,949,041$1,077,310,473.14$12,794$703.91+$1080.94M → PEARW
3$321,205,007,173$320,048,391,699.27$14,518$829.07+$321204.99M → PEARW
4$89,224,694,578,678$88,881,005,221,002.70$16,513$978.64+$89224694.56M → PEARW
5$23,169,738,996,241,900$23,074,268,573,042,710.00$18,827$1,157.84+$23169738996.22M → PEARW
6$5,624,691,175,493,529,000$5,599,899,554,767,550,000.00$21,518$1,373.12+$5624691175493.51M → PEARW
7$1,276,516,462,323,700,300,000$1,270,498,042,765,922,300,000.00$24,657$1,632.46+$1276516462323700.25M → PEARW
8$270,840,549,707,403,520,000,000$269,474,677,092,717,130,000,000.00$28,329$1,945.74+$270840549707403520.00M → PEARW
9$53,724,262,376,359,350,000,000,000$53,434,462,988,172,430,000,000,000.00$32,637$2,325.33+$53724262376359346176.00M → PEARW
10$9,963,396,520,724,353,000,000,000,000$9,905,911,559,981,649,000,000,000,000.00$37,708$2,786.64+$9.963396520724352e+21M → PEARW

PEARW vs BTI: Complete Analysis 2026

PEARW — Stock

Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.

Full PEARW Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this PEARW vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEARW vs SCHDPEARW vs JEPIPEARW vs OPEARW vs KOPEARW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.